FIELD: pharmaceutical chemistry, medicine.
SUBSTANCE: invention relates to substituted pyridines and pyridazines with angiogenesis inhibition activity of general formula I
(I)1, wherein ring containing A, B, D, E, and L represents phenyl or nitrogen-containing heterocycle; X and Y are various linkage groups; R1 and R2 are identical or different and represent specific substituents or together form linkage ring; ring J represents aryl, pyridyl or cycloalkyl; and G's represent various specific substituents. Also disclosed are pharmaceutical composition containing claimed compounds, as well as method for treating of mammalian with abnormal angiogenesis or treating of increased penetrability using the same.
EFFECT: new pyridine and pyridazine derivatives with angiogenesis inhibition activity.
26 cl, 6 tbl, 114 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOUNDS FOR USE IN TREATMENT OF MUCOSITIS | 2012 |
|
RU2606128C2 |
| NOVEL ANTICONVULSIVE SUBSTITUTED SULFAMATE DERIVATIVES | 2003 |
|
RU2328502C2 |
| N-PHENYL-2-PYRIMIDINE DERIVATIVES | 2003 |
|
RU2370493C2 |
| 3-CYANOQUINOLIMES AS INHIBITORS OF EGF-R AND HER2 KINASES | 2002 |
|
RU2309150C2 |
| BICYCLIC PYRIDINES AND PYRIMIDINES AS KINASE P38 INHIBITORS | 2003 |
|
RU2301233C2 |
| NEW INHIBITORS OF 17 β-HYDROXYSTEROID-DEHYDROGENASE TYPE I | 2004 |
|
RU2369614C2 |
| METHOD OF RESIDUAL LIPOPROTEINS PRODUCING INHIBITION | 2004 |
|
RU2330682C2 |
| METHOD OF TREATING POLYCYSTIC KIDNEY DISEASES BY CERAMIDE DERIVATIVES | 2008 |
|
RU2517345C9 |
| COMBINED THERAPY INCLUDING SGLT INHIBITORS AND DPP4 INHIBITORS | 2009 |
|
RU2481106C2 |
| DERIVATIVES OF 2-AMINONICOTINE AMIDE AND THEIR USING AS INHIBITORS OF TYROSINE KINASE VEGF RECEPTORS | 2001 |
|
RU2296124C2 |
